ストックスクリーナーアプリを入手
0.6838
4.75%
-0.0341
プレマーケット:
.71
0.0262
+3.83%
Mersana Therapeutics Inc (MRSN) 最新ニュース
Mersana Therapeutics Posts Updated Corporate Presentation on Company Website - Armenian Reporter
William Blair Initiates Coverage of Mersana Therapeutics (MRSN) with Outperform Recommendation - MSN
Mersana initiated at outperform at William Blair on antibody-drug conjugate potential - Seeking Alpha
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
William Blair starts Mersana stock with Outperform rating - MSN
Mersana Therapeutics Inc [MRSN] Shares Rise 18.66 % on Wednesday - Knox Daily
Mersana Therapeutics Updates Investor Presentation Online - TipRanks
Investors in cash trouble should check out Mersana Therapeutics Inc (MRSN) - SETE News
MRSNMersana Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewswire
Exclusive: Mersana Therapeutics CEO to Reveal ADC Pipeline Updates at Guggenheim Conference - StockTitan
Apple Swings to Outperformer: Is It a Buy Ahead of Earnings? - The Globe and Mail
MRSN News Today | Why did Mersana Therapeutics stock go down today? - MarketBeat
Brokerages Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) PT at $5.57 - MarketBeat
MRSN stock touches 52-week low at $0.56 amid market challenges - MSN
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives $5.57 Average Price Target from Analysts - MarketBeat
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
MRSN stock touches 52-week low at $0.56 amid market challenges By Investing.com - Investing.com South Africa
Mersana Therapeutics' SVP sells shares worth $4,912 - MSN
Mersana Therapeutics chief development officer sells shares worth $3,444 - MSN
Mersana Therapeutics CEO sells $2,618 in stock - MSN
Mersana Therapeutics' chief accounting officer sells shares worth $2,061 - MSN
Mersana Therapeutics officer Timothy Lowinger sells $4,667 in stock - MSN
Mersana Therapeutics officer Timothy Lowinger sells $4,667 in stock By Investing.com - Investing.com South Africa
Mersana Therapeutics SVP sells $2,955 in stock By Investing.com - Investing.com South Africa
Mersana Therapeutics' chief accounting officer sells shares worth $2,061 By Investing.com - Investing.com Australia
Mersana Therapeutics CEO sells $2,618 in stock By Investing.com - Investing.com Australia
Mersana Therapeutics' SVP sells shares worth $4,912 By Investing.com - Investing.com South Africa
Mersana Therapeutics SVP sells $2,955 in stock - MSN
Mersana therapeutics VP Mandelia sells $1,128 in stock - MSN
Mersana therapeutics' chief officer sells shares worth $1,130 - MSN
JPMorgan Chase & Co. Grows Stock Holdings in Mersana Therapeutics, Inc. (NASDAQ:MRSN) - Defense World
Mersana therapeutics director Anna Protopapas sells shares worth $5,009 - MSN
Mersana Therapeutics’ chief accounting officer sells shares worth $2,061 By Investing.com - Investing.com Nigeria
Mersana Therapeutics chief development officer sells shares worth $3,444 By Investing.com - Investing.com South Africa
Mersana therapeutics director Anna Protopapas sells shares worth $5,009 By Investing.com - Investing.com Canada
0.82%
0.53%
大文字化:
|
ボリューム (24 時間):